FDA Inspection 718476 — ImpactLife

ImpactLife — FEI 1470264

The FDA completed an inspection of ImpactLife on April 6, 2011 in Moline, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Moline, IL (United States)